Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

03.03.2025

1 Ann Surg Oncol
5 BMC Cancer
1 Breast Cancer
4 Breast Cancer (Dove Med Press)
3 Breast Cancer Res
5 Breast Cancer Res Treat
4 Breast J
1 Cancer
1 Cancer Res
1 Clin Breast Cancer
2 Clin Cancer Res
2 Eur J Cancer
2 Eur J Surg Oncol
5 Int J Radiat Oncol Biol Phys
1 J Biol Chem
2 J Clin Oncol
3 Nature
1 NPJ Breast Cancer
1 Oncogene
1 PLoS Comput Biol
3 PLoS One
2 Proc Natl Acad Sci U S A
1 Radiol Imaging Cancer


    Ann Surg Oncol

  1. BOROWSKY PA, Hernandez AE, Kesmodel SB, Goel N, et al
    Genetic Ancestry and 21-Gene Oncotype DX Breast Cancer Recurrence Scores.
    Ann Surg Oncol. 2025 Feb 27. doi: 10.1245/s10434-025-17012.
    >> Share


    BMC Cancer

  2. XIE L, Kong X, Lin D, Song J, et al
    Application of chest wall perforator flaps in oncoplastic breast-conserving surgery.
    BMC Cancer. 2025;25:328.
    >> Share

  3. LI Y, Song W, Gao P, Guan X, et al
    Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021.
    BMC Cancer. 2025;25:330.
    >> Share

  4. WONGMANEERUNG P, Chitapanarux I, Traisathit P, Prasitwattanaseree S, et al
    The association between Ki-67 expression and survival in breast cancer subtypes: a cross-sectional study of Ki-67 cut-point in northern Thailand.
    BMC Cancer. 2025;25:346.
    >> Share

  5. HAYES BL, Fleming L, Mahmoud O, Martin RM, et al
    The impact of sleep on breast cancer-specific mortality: a Mendelian randomisation study.
    BMC Cancer. 2025;25:357.
    >> Share

  6. YAN M, Zong Z, Guo W, Li X, et al
    PIK3CA gene mutation status associated with poor prognosis of breast cancer: a retrospective cohort study.
    BMC Cancer. 2025;25:365.
    >> Share


    Breast Cancer

  7. WU SI, Chen VC, Hsu YH, Tzang BS, et al
    Contemporaneous changes in cytokines and cognitive function during chemotherapy in patients with breast cancer: a prospective follow-up study.
    Breast Cancer. 2025 Feb 25. doi: 10.1007/s12282-025-01668.
    >> Share


    Breast Cancer (Dove Med Press)

  8. GU H, Zhu T, Ding J, Yang Z, et al
    Real-World Analysis of the Efficacy and Adverse Events of T-DM1 in Chinese Patients With HER2-Positive Breast Cancer.
    Breast Cancer (Dove Med Press). 2025;17:201-210.
    >> Share

  9. ONER G, Praet MM, Stoop H, Devi GR, et al
    Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer.
    Breast Cancer (Dove Med Press). 2025;17:211-224.
    >> Share

  10. YANG X, Li J, Sun H, Chen J, et al
    Radiomics Integration of Mammography and DCE-MRI for Predicting Molecular Subtypes in Breast Cancer Patients.
    Breast Cancer (Dove Med Press). 2025;17:187-200.
    >> Share

  11. ALJADANI FF, Nughays RO, Alharbi GE, Almazroy EA, et al
    Quality of Life in Breast Cancer Patients in Saudi Arabia: A Systematic Review.
    Breast Cancer (Dove Med Press). 2025;17:171-186.
    >> Share


    Breast Cancer Res

  12. FENG X, Shi Y, Wu M, Cui G, et al
    Predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients based on ultrasound longitudinal temporal depth network fusion model.
    Breast Cancer Res. 2025;27:30.
    >> Share

  13. SHI Q, Yang W, Ouyang Y, Liu Y, et al
    Correction: CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer.
    Breast Cancer Res. 2025;27:28.
    >> Share

  14. WU X, Xia Y, Lou X, Huang K, et al
    Decoding breast cancer imaging trends: the role of AI and radiomics through bibliometric insights.
    Breast Cancer Res. 2025;27:29.
    >> Share


    Breast Cancer Res Treat

  15. RANDALL ARMEL S, Malcolmson J, Volenik A, Maganti M, et al
    Genetic counseling referral rates and genetic testing outcomes in women with young breast cancer: a 20-year Canadian review.
    Breast Cancer Res Treat. 2025 Feb 22. doi: 10.1007/s10549-025-07646.
    >> Share

  16. CHANDEKAR KR, Satapathy S, Dharmashaktu Y, Ballal S, et al
    Somatostatin receptor-targeted theranostics in patients with estrogen receptor-positive metastatic breast cancer-a prospective exploratory study.
    Breast Cancer Res Treat. 2025 Feb 26. doi: 10.1007/s10549-025-07651.
    >> Share

  17. TERVASMAKI A, Kumpula TA, Grip M, Koivuluoma S, et al
    Population-based study of recurrent DNA damage response gene variants in breast cancer cases.
    Breast Cancer Res Treat. 2025 Feb 26. doi: 10.1007/s10549-025-07634.
    >> Share

  18. SULLIVAN M, Lei X, Karuturi M, Malinowski C, et al
    Use of adjuvant capecitabine in older patients with early-stage triple-negative breast cancer.
    Breast Cancer Res Treat. 2025 Feb 28. doi: 10.1007/s10549-025-07637.
    >> Share

  19. KIM SH, Park GE, Bertrand KA, Sandler DP, et al
    Mammographic density as a predictor of invasive breast cancer and ductal carcinoma in situ in over six million South Korean women.
    Breast Cancer Res Treat. 2025 Feb 28. doi: 10.1007/s10549-025-07648.
    >> Share


    Breast J

  20. JOURNAL TB
    NOTIFICATION: The Role of Pathologists in Recognition of Morphologic and Biologic Features of Genetically Mutated Breast Cancer.
    Breast J. 2025;2025:9823045.
    >> Share

  21. HASHMI AA, Ajaz Y, Sajjad M, Zia F, et al
    Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers.
    Breast J. 2025;2025:8410670.
    >> Share

  22. WANG Z, Li Q, Wang Y, Qian L, et al
    Diagnosis of Benign and Malignant Newly Developed Nodules on the Surgical Side After Breast Cancer Surgery Based on Machine Learning.
    Breast J. 2025;2025:8511049.
    >> Share

  23. JOURNAL TB
    NOTIFICATION: Development of a Novel Approach for Breast Cancer Prediction and Early Detection Using Minimally Invasive Procedures and Molecular Analysis: How Cytomorphology Became a Breast Cancer Risk Predictor.
    Breast J. 2025;2025:9806762.
    >> Share


    Cancer

  24. PATEL RB, Sheng T, Diniz MA, Sparano JA, et al
    Impact of race/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: A National Cancer Data Base analysis.
    Cancer. 2025;131:e35771.
    >> Share


    Cancer Res

  25. SUN Z, Li Z, Wei Y, Xu L, et al
    SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2801.
    >> Share


    Clin Breast Cancer

  26. LI ZY, Wu SN, Lin P, Jiang MC, et al
    Habitat-Based Radiomics for Revealing Tumor Heterogeneity and Predicting Residual Cancer Burden Classification in Breast Cancer.
    Clin Breast Cancer. 2025 Feb 4:S1526-8209(25)00028.
    >> Share


    Clin Cancer Res

  27. LIN CA, Chica-Parrado MR, Unni N, Jaeger E, et al
    ESR1 Y537S and D538G mutations drive resistance to CDK4/6 inhibitors in estrogen receptor-positive breast cancer.
    Clin Cancer Res. 2025 Feb 25. doi: 10.1158/1078-0432.CCR-24-2307.
    >> Share

  28. FASCHING PA, Slamon D, Nowecki Z, Kukielka-Budny B, et al
    Health-related quality of life in patients with HR+/HER2- early breast cancer treated with ribociclib plus a nonsteroidal aromatase inhibitor: results from the NATALEE trial.
    Clin Cancer Res. 2025 Feb 28. doi: 10.1158/1078-0432.CCR-24-1724.
    >> Share


    Eur J Cancer

  29. GRIGUOLO G, Bottosso M, Crema A, Giarratano T, et al
    Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomes.
    Eur J Cancer. 2025;219:115321.
    >> Share

  30. STEGER K, Fiegl H, Feroz B, Leitner K, et al
    Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer.
    Eur J Cancer. 2025;219:115320.
    >> Share


    Eur J Surg Oncol

  31. CATANUTO G, Gentile D, Martorana F, Tomatis M, et al
    Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database.
    Eur J Surg Oncol. 2025;51:109643.
    >> Share

  32. CABIOGLU N, Karanlik H, Igci A, Uras C, et al
    Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study.
    Eur J Surg Oncol. 2025;51:109642.
    >> Share


    Int J Radiat Oncol Biol Phys

  33. YANG K, Zhang Y, Li S, Chen L, et al
    Multimodal Photoacoustic/Elastography Imaging for the Detection of Acute Radiation Dermatitis in Breast Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;121:910-917.
    >> Share

  34. BRAUNSTEIN LZ, Boe L, Mueller B, Obrien DR, et al
    Accelerated Partial Breast Irradiation for Early-Stage Invasive Lobular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025;121:894-899.
    >> Share

  35. TAGHIAN AG, Naoum GE, Braunstein LZ, Niemierko A, et al
    Defining the Optimal Dose for 3-Dimensional Conformal Accelerated Partial Breast Irradiation: 15-Year Follow-Up of a Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:900-909.
    >> Share

  36. REVERBERI C, Facondo G, Prisco A, Ceschia T, et al
    Pre-Operative Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer Patients with Gammapod Technology: Pathological Findings and Ki-67 Evaluation.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00152.
    >> Share

  37. SALARI K, Lee JS, Mumaw DA, Almahariq MF, et al
    Regional Near-surface Dose Predicts Moist Desquamation and Implant Failure in Patients Receiving Radiation Therapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Feb 24:S0360-3016(25)00148.
    >> Share


    J Biol Chem

  38. BOBBITT JR, Cuellar-Vite L, Weber-Bonk KL, Yancey MR, et al
    Targeting the mitotic kinase NEK2 enhances CDK4/6 inhibitor efficacy by potentiating genome instability.
    J Biol Chem. 2025;301:108196.
    >> Share


    J Clin Oncol

  39. MONTAGNA G, Laws A, Ferrucci M, Mrdutt MM, et al
    Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.
    J Clin Oncol. 2025;43:810-820.
    >> Share

  40. LAMBERTINI M, Blondeaux E, Tomasello LM, Agostinetto E, et al
    Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.
    J Clin Oncol. 2025 Feb 24:JCO2401334. doi: 10.1200/JCO-24-01334.
    >> Share


    Nature

  41. GUGLIELMI G
    Breast cancer is on the rise: data reveal drastic gap in survival rates.
    Nature. 2025 Feb 24. doi: 10.1038/d41586-025-00265.
    >> Share

  42. XIE F, Zhou X, Ran Y, Li R, et al
    Targeting FOXM1 condensates reduces breast tumour growth and metastasis.
    Nature. 2025;638:1112-1121.
    >> Share

  43. DU Z, Wang H, Luo S, Yun Z, et al
    The sequence-structure-function relationship of intrinsic ERalpha disorder.
    Nature. 2025;638:1130-1138.
    >> Share


    NPJ Breast Cancer

  44. TAMIRISA N, Dong W, Shen Y, Lin H, et al
    Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer.
    NPJ Breast Cancer. 2025;11:21.
    >> Share


    Oncogene

  45. WITKIEWICZ AK, Wang J, Schultz E, O'Connor TN, et al
    Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer.
    Oncogene. 2025 Feb 26. doi: 10.1038/s41388-025-03308.
    >> Share


    PLoS Comput Biol

  46. SAKAI SA, Nomura R, Nagasawa S, Chi S, et al
    SpatialKNifeY (SKNY): Extending from spatial domain to surrounding area to identify microenvironment features with single-cell spatial omics data.
    PLoS Comput Biol. 2025;21:e1012854.
    >> Share


    PLoS One

  47. DONG J, Lei R, Ma F, Yu L, et al
    Machine learning-based prediction of distant metastasis risk in invasive ductal carcinoma of the breast.
    PLoS One. 2025;20:e0310410.
    >> Share

  48. KHAN MA, Khan ZA, Husain I, Upadhyay S, et al
    Effects of pressure on the survival and viability of cancer cells in vitro: An analytical study.
    PLoS One. 2025;20:e0311685.
    >> Share


  49. Retraction: A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
    PLoS One. 2025;20:e0319490.
    >> Share


    Proc Natl Acad Sci U S A

  50. STAROSTECKA M, Jeong H, Hasenfeld P, Benito-Garagorri E, et al
    Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model.
    Proc Natl Acad Sci U S A. 2025;122:e2415475122.
    >> Share


  51. Correction for Qin et al., A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells.
    Proc Natl Acad Sci U S A. 2025;122:e2502214122.
    >> Share


    Radiol Imaging Cancer

  52. JIRARAYAPONG J, Portnow LH, Jagadeesan J, Kwait DC, et al
    Intraoperative Supine Breast MRI for Residual Tumor Assessment after Breast-Conserving Therapy in Early-Stage Breast Cancer.
    Radiol Imaging Cancer. 2025;7:e240158.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016